Antituberculous Agents for Pediatric Mycobacterial Diseases, and Hearing Loss
- 11 November 2023
- book chapter
- Published by Springer Nature
- p. 1065-1094
Abstract
No abstract availableKeywords
This publication has 150 references indexed in Scilit:
- Hearing loss in children treated for multidrug-resistant tuberculosisJournal of Infection, 2013
- New developments in aminoglycoside therapy and ototoxicityHearing Research, 2011
- Multidrug-resistant tuberculosis (MDR-TB) treatment in the UK: a study of injectable use and toxicity in practiceJournal of Antimicrobial Chemotherapy, 2011
- Natural History of Tuberculosis: Duration and Fatality of Untreated Pulmonary Tuberculosis in HIV Negative Patients: A Systematic ReviewPLOS ONE, 2011
- Investigation of mitochondrial sequence variants associated with aminoglycoside-induced ototoxicity in South African TB patients on aminoglycosidesBiochemical and Biophysical Research Communications, 2010
- Audiologic monitoring of multi-drug resistant tuberculosis patients on aminoglycoside treatment with long term follow-upBMC Ear, Nose and Throat Disorders, 2007
- Ototoxicity caused by aminoglycosidesBMJ, 2007
- Mitochondrial 12S rRNA gene mutations affect RNA secondary structure and lead to variable penetrance in hearing impairmentBiochemical and Biophysical Research Communications, 2006
- Familial aggregation of streptomycin ototoxicity: autosomal dominant inheritance?Journal of Medical Genetics, 1983
- STREPTOMYCES ANTIBIOTICS. IX. DIHYDROSTREPTOMYCINJournal of the American Chemical Society, 1946